Regulatory Open Forum

 View Only
  • 1.  Recall in the US for medical device

    This message was posted by a user wishing to remain anonymous
    Posted 26-Jan-2023 09:21
    This message was posted by a user wishing to remain anonymous

    Hi All, 

    I have seen many discussions that pertains to recalls of medical device with the FDA. I am still having a hard time understanding the difference between 21 CFR 806 vs 21 CFR 7.

    My lack of understanding is when does each become applicable. To me the definition of correction and removal sounds the same as recall and so CFR 806 covers the requirements?

    If every issue in the filed for a medical device manufacturers is a correction and removal, when will it possibly be that the manufacturer has to abide by CFR 7? I understand that CFR 7 is voluntary recall, but there is a section that talks about "firm-initiated recall", when is this applicable? I feel like both the class I and II recall falls under CFR 806 and class II is not required to be reported to the FDA. Can someone help me understand, if possible with examples, as to when CFR 7 would be applicable to medical device manufacturer?

    Thank you all.



  • 2.  RE: Recall in the US for medical device

    Posted 26-Jan-2023 10:02
    Edited by Ian Broome 26-Jan-2023 10:03
    Hello Anon,

    I'll let others weigh in on the CFR 7 question, but keep in mind that there are various terms and activities here, and not all are the same thing. For example, the following two examples of correction/removal would not generally be considered a full Recall:

    A Stock Recovery is the correction or removal of a device that has not been marketed, or that has not left the direct control of the manufacturer, i.e., the device is located on the premises owned by the manufacturer, or under the control of the manufacturer (like a distributor's warehouse) AND no portion of the lot/model/code or other relevant unit involved in the corrective action or removal action has been released for sale or use.

    Field Safety Corrective Action is an action taken to correct a deficiency in product that has already been released from distribution centers to customers in the field. It is not a recall or a stock recovery; it falls somewhere between the two. It could simply involve sending out a notice or updated IFUs/labels or it could involve sending out technicians to correct settings or fix product in the field.

    ------------------------------
    Ian Broome, M.S., RAC
    Needham, MA
    United States
    ***Any posts or activity shared on RAPS Forums are my own personal views; I do not speak on behalf of Boston Scientific Corporation (BSC).***
    ------------------------------



  • 3.  RE: Recall in the US for medical device

    Posted 26-Jan-2023 10:22
    Edited by Kevin Randall 26-Jan-2023 10:30

    The most succinct way I've seen FDA correlate 21 CFR Part 806 with 21 CFR Part 7 is by stating that Part 806 reports of corrections and removals are required for Part 7 Class I and Class II recalls, yet not for Part 7 Class III recalls.  Specifically, manufacturers and importers are required to make a Part 806 report to FDA of any correction or removal of a medical device(s) if the correction or removal was initiated to reduce a risk to health posed by the device or to remedy a violation of the act caused by the device which may present a risk to health.

    Having addressed when Part 806 becomes applicable, let's now focus more on when Part 7 becomes applicable.  Specifically, Part 7 has two distinct purposes:

     

    • Regulation of FDA's own internal practices and procedures applicable to regulatory actions (e.g., recalls) initiated by (i.e., forced by) the FDA in urgent situations as an alternative to an FDA-initiated court action.

    • "Guidance" for manufacturers and distributors for their "voluntary" removal or correction (i.e., their voluntary "recall" or "market withdrawal") of marketed products so that such voluntary actions are discharged in a way that is effective in FDA's eyes.

     

    In practice, if FDA detects and believes that a product needs to be recalled for protection of public health, then the agency will "suggest" to a firm that the firm should "consider" recalling the device.  Let me translate this: This means the firm is essentially being ordered by FDA to recall the device, or else FDA will force the recall and will, if needed, resort to legal actions against the firm.  This comes from the essence of the official definition of "recall": A firm's removal or correction of a marketed product that the FDA considers to be in violation of the laws it administers and against which the agency would initiate legal action, e.g., seizure (e.g., if the firm doesn't voluntarily cooperate) [interpretive emphasis added].

     

    So, ultimately, Part 7's "voluntary" scope as applied to manufacturers and importers isn't really voluntary, as those firms would alternatively be forced by the agency.

     

    Ultimately, the most efficient and effective way for a firm to put a recall in its rear-view mirror and get back to business is by executing and documenting the recall following the recall steps outlined by Part 7 while being sure to report via Part 806 those recalls that meet the aforementioned Part 806 reporting criteria.  For example, when I do a Part 806 report for a Class I or II recall, there are certain section 806.10(c) elements [e.g., subsections 7, 8, 9, 12, etc.] that are addressed via the section 7.41, 7.42, and 7.49 health hazard evaluation, recall strategy, and recall communications.  Same thing, by the way, for the non-reportable 806.20 corrections or removals (e.g., Part 7 Class III recalls and market withdrawals).

    For your lingering questions about the definitions, I'll expand on the aforesaid "recall" definition by explaining that all recalls are either a correction or removal, but not all corrections or removals are recalls.  The classic example of this is a "market withdrawal", which means a correction or removal of a distributed product which involves a minor violation that would not be subject to FDA legal action or which involves no violation, e.g., normal stock rotation practices, routine equipment adjustments and repairs, etc.

     

    Hope this helps.

    ------------------------------
    Kevin Randall, ASQ CQA, RAC (U.S., Europe, Canada)
    Principal Consultant
    Ridgway, CO
    United States
    © Copyright 2023 by ComplianceAcuity, Inc. All rights reserved.
    ------------------------------



  • 4.  RE: Recall in the US for medical device

    Posted 26-Jan-2023 10:30
    Note also that Field Safety Corrective Action (FSCA) is not a concept directly recognized by the U.S. FDA. Instead, FSCA is a term of Europe's medical device regulations.  This is important to note because FSCA (and also Europe's definition of "recall") contains elements that conflict with the U.S. FDA's definition of "recall".  Therefore be careful not to equate European medical device FSCA with U.S. FDA recall.

    ------------------------------
    Kevin Randall, ASQ CQA, RAC (U.S., Europe, Canada)
    Principal Consultant
    Ridgway, CO
    United States
    © Copyright 2023 by ComplianceAcuity, Inc. All rights reserved.
    ------------------------------



  • 5.  RE: Recall in the US for medical device

    Posted 26-Jan-2023 13:19

    The easiest way to think about distinguishes the role and scope of the regulations.

    Part 7 is generic and applies to all products that FDA regulates. In addition, Part 7 is for FDA to follow.

    In contrast, Part 806 is specific to medical devices and is for the manufacturer to follow.

    A manufacturer files a report to FDA under Part 806. This triggers FDA to determine if it is recall and, if so, the recall class. If FDA determines the manufacturer's report is a recall they will classify it as a voluntary recall (as opposed to a mandatory recall under Part 810) and inform the manufacturer of additional steps.

    As a medical device manufacturer, implement Part 806. Then, if FDA provides additional instructions, follow them.

    In term of language, the device manufacturer initiates a correction or removal. Only FDA can declare it a recall.

     



    ------------------------------
    Dan O'Leary CQA, CQE
    Swanzey NH
    United States
    ------------------------------